EV/EBITDA
-0.04
0.000.00%
Thu, 13 Mar 2025 23:58:35 GMT
Summary
- As of March 14, 2025, SYRS EV/EBITDA is -0.04, unchanged from the previous trading day.
- Over the past year, SYRS EV/EBITDA has increased by +0.61 (+93.85%).
- SYRS EV/EBITDA is now -107.14% below its all-time high of 0.56.
Performance
SYRS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SYRS EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | +5.3% | +10.8% |
1 m1 month | +42.9% | -40.8% | -57.1% |
3 m3 months | +50.0% | -47.6% | -63.8% |
6 m6 months | +93.2% | -92.5% | -96.0% |
ytdytd | +55.6% | -50.7% | -66.5% |
1 y1 year | +93.8% | -96.0% | -98.8% |
5 y5 years | +98.6% | -98.0% | -99.8% |
SYRS EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | at high | -0.08 | +50.0% | |
3 m | 3-month | -0.04 | at high | -0.10 | +60.0% |
6 m | 6-month | -0.04 | at high | -1.02 | +96.1% |
1 y | 1-year | -0.04 | at high | -1.29 | +96.9% |
3 y | 3-year | 0.56 | -107.1% | -1.50 | +97.3% |
5 y | 5-year | 0.56 | -107.1% | -11.54 | +99.7% |
alltime | all time | 0.56 | -107.1% | -11.54 | +99.7% |
Syros Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -0.04(-55.6%) |
2024 | -0.09(-89.3%) |
2023 | -0.84(-333.3%) |
2022 | 0.36(-116.4%) |
2021 | -2.20(-65.3%) |
Date | Value |
---|---|
2020 | -6.34(+62.1%) |
2019 | -3.91(+71.5%) |
2018 | -2.28(-46.1%) |
2017 | -4.23(-12.6%) |
2016 | -4.84 |
FAQ
- What is Syros Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Syros Pharmaceuticals?
- What is SYRS EV/EBITDA year-to-date change?
- What is Syros Pharmaceuticals EV/EBITDA year-on-year change?
What is Syros Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SYRS is -0.04
What is the all time high EV/EBITDA for Syros Pharmaceuticals?
Syros Pharmaceuticals all-time high EV/EBITDA is 0.56
What is SYRS EV/EBITDA year-to-date change?
Syros Pharmaceuticals EV/EBITDA has changed by +0.05 (+55.56%) since the beginning of the year
What is Syros Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SYRS EV/EBITDA has changed by +0.61 (+93.85%)